These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

702 related items for PubMed ID: 8831996

  • 1. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood.
    Mills KC, Gross TG, Varney ML, Heimann DG, Reed EC, Kessinger A, Talmadge JE.
    Bone Marrow Transplant; 1996 Jul; 18(1):53-61. PubMed ID: 8831996
    [Abstract] [Full Text] [Related]

  • 2. Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation.
    Talmadge JE, Reed EC, Kessinger A, Kuszynski CA, Perry GA, Gordy CL, Mills KC, Thomas ML, Pirruccello SJ, Letheby BA, Arneson MA, Jackson JD.
    Bone Marrow Transplant; 1996 Jan; 17(1):101-9. PubMed ID: 8673041
    [Abstract] [Full Text] [Related]

  • 3. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow.
    Talmadge JE, Reed E, Ino K, Kessinger A, Kuszynski C, Heimann D, Varney M, Jackson J, Vose JM, Bierman PJ.
    Bone Marrow Transplant; 1997 Jan; 19(2):161-72. PubMed ID: 9116614
    [Abstract] [Full Text] [Related]

  • 4. Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts.
    Theilgaard-Mönch K, Raaschou-Jensen K, Palm H, Schjødt K, Heilmann C, Vindeløv L, Jacobsen N, Dickmeiss E.
    Bone Marrow Transplant; 2001 Dec; 28(11):1073-82. PubMed ID: 11781619
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both.
    Ho AD, Young D, Maruyama M, Corringham RE, Mason JR, Thompson P, Grenier K, Law P, Terstappen LW, Lane T.
    Exp Hematol; 1996 Nov; 24(13):1460-8. PubMed ID: 8950228
    [Abstract] [Full Text] [Related]

  • 9. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
    Fritsch G, Stimpfl M, Kurz M, Printz D, Buchinger P, Fischmeister G, Hoecker P, Gadner H.
    Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
    [Abstract] [Full Text] [Related]

  • 10. GM-CSF-mobilized peripheral blood CD34+ cells differ from steady-state bone marrow CD34+ cells in adhesion molecule expression.
    Watanabe T, Dave B, Heimann DG, Lethaby E, Kessinger A, Talmadge JE.
    Bone Marrow Transplant; 1997 Jun; 19(12):1175-81. PubMed ID: 9208110
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunoregulatory cytokines in bone marrow and peripheral blood stem cell products.
    Singh RK, Ino K, Varney ML, Heimann DG, Talmadge JE.
    Bone Marrow Transplant; 1999 Jan; 23(1):53-62. PubMed ID: 10037051
    [Abstract] [Full Text] [Related]

  • 13. IL-2-activated cord blood mononuclear cells.
    Derzic S, Slone V, Sender L.
    Cytotherapy; 2005 Jan; 7(5):408-16. PubMed ID: 16236630
    [Abstract] [Full Text] [Related]

  • 14. Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
    Choi D, Perrin M, Hoffmann S, Chang AE, Ratanatharathorn V, Uberti J, McDonagh KT, Mulé JJ.
    Clin Cancer Res; 1998 Nov; 4(11):2709-16. PubMed ID: 9829733
    [Abstract] [Full Text] [Related]

  • 15. Phenotypic and functional characterization of peripheral blood and bone marrow natural killer cells prior to autologous transplantation.
    Arbour S, Toupin S, Bélanger R, Gyger M, Hallé JP, Perreault C, Roy DC.
    Bone Marrow Transplant; 1996 Mar; 17(3):315-22. PubMed ID: 8704680
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
    Hassan HT, Zeller W, Stockschläder M, Krüger W, Hoffknecht MM, Zander AR.
    Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
    [Abstract] [Full Text] [Related]

  • 18. Antitumor and accessory immune activities of peripheral blood stem cells mobilized with granulocyte-macrophage colony-stimulating factor.
    Triozzi PL, Tucker F, Benzies T, Balcerzak SP.
    Bone Marrow Transplant; 1996 Jul; 18(1):47-52. PubMed ID: 8831995
    [Abstract] [Full Text] [Related]

  • 19. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J, Broxmeyer HE.
    Cell Immunol; 1997 Sep 15; 180(2):132-42. PubMed ID: 9341743
    [Abstract] [Full Text] [Related]

  • 20. Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure.
    Maciejewski JP, Hibbs JR, Anderson S, Katevas P, Young NS.
    Exp Hematol; 1994 Oct 15; 22(11):1102-10. PubMed ID: 7925777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.